These CAR T-cells effectively eliminated B7 H3-positive ovarian cancer cells both in vitro and in orthotopic/metastatic xenograft mouse models, including patient-derived tumors, significantly reducing tumor burden and improving survival without apparent toxicity [99]. This evidence concerns the gene CD276 and ovarian carcinoma.